Latest News

Developed by Geneoscopy and offered commercially through Labcorp, ColoSense is intended for adults aged 45 to 85 years who are considered to have an average risk of colorectal cancer.

The acquisition gives Zymeworks access to Yupelri, an FDA-approved, once-daily nebulized maintenance therapy for chronic obstructive pulmonary disease (COPD) that Theravance markets in partnership with Viatris.

The expanded facility will combine inpatient rehabilitation, outpatient specialty clinics, orthopaedic and musculoskeletal care, neurosciences, sports medicine, physical medicine, and cardiac rehabilitation within a single coordinated care model.

The initiative combines “Care for Her” by Aster Hospitals & Clinics and “Elle by Medcare,” a premium programme offered through Medcare hospitals and medical centres.

Surgeons completed the entire procedure through a 16 mm incision while the patient remained fully awake, eliminating the need for general anaesthesia.

Media, events and digital solutions company unveil new identity to reflect broader regional footprint and integrated business services.

The new system increases the Mega Lab’s haematology testing capacity to more than 1,000 tests per hour while reducing manual handling throughout the testing workflow.

Unlike CAR-T therapy, which requires patient-specific cell modification and lengthy manufacturing, this treatment is delivered as a ready-to-use infusion, making it more accessible in standard hospital settings.

Ohana Specialist Hospital is a 30-bed private facility that specializes in paediatrics as well as obstetrics and gynaecology.

Closing this gap would benefit not only patients but also their families and healthcare systems while supporting the Gulf’s broader vision of compassionate, patient-centred care.